WDNA holdings
WisdomTree BioRevolution Fund
Positions
81 stored of 81 reported, largest first by weight
| # | Holding | ISIN | CUSIP | Weight | Value (USD) | Type | Issuer type | Country | Currency |
|---|---|---|---|---|---|---|---|---|---|
| 1 | TWIST BIOSCIENCE CORP TWIST BIOSCIENCE CORP COM | US90184D1000 | 90184D100 | 5.949% | $159K | Equity (common) | Corporate | United States | USD |
| 2 | MODERNA INC MODERNA INC COM | US60770K1079 | 60770K107 | 4.143% | $111K | Equity (common) | Corporate | United States | USD |
| 3 | ELI LILLY & COMPANY ELI LILLY & COMPANY COM | US5324571083 | 532457108 | 4.077% | $109K | Equity (common) | Corporate | United States | USD |
| 4 | JOHNSON & JOHNSON JOHNSON & JOHNSON COM | US4781601046 | 478160104 | 2.969% | $79K | Equity (common) | Corporate | United States | USD |
| 5 | UNITED THERAPEUTICS CORP UNITED THERAPEUTICS CORP COM | US91307C1027 | 91307C102 | 2.449% | $66K | Equity (common) | Corporate | United States | USD |
| 6 | NATERA INC NATERA INC COM | US6323071042 | 632307104 | 2.322% | $62K | Equity (common) | Corporate | United States | USD |
| 7 | TEMPUS AI INC TEMPUS AI INC CL A | US88023B1035 | 88023B103 | 2.283% | $61K | Equity (common) | Corporate | United States | USD |
| 8 | IMMUNOME INC IMMUNOME INC COM | US45257U1088 | 45257U108 | 2.256% | $60K | Equity (common) | Corporate | United States | USD |
| 9 | STRUCTURE THERAPEUTICS INC STRUCTURE THERAPEUTICS INC SPONSORED ADS | US86366E1064 | 86366E106 | 2.115% | $57K | Equity (common) | Corporate | Cayman Islands | USD |
| 10 | STOKE THERAPEUTICS INC STOKE THERAPEUTICS INC COM | US86150R1077 | 86150R107 | 2.092% | $56K | Equity (common) | Corporate | United States | USD |
| 11 | BEAM THERAPEUTICS INC BEAM THERAPEUTICS INC COM | US07373V1052 | 07373V105 | 2.087% | $56K | Equity (common) | Corporate | United States | USD |
| 12 | CORTEVA INC CORTEVA INC COM | US22052L1044 | 22052L104 | 1.990% | $53K | Equity (common) | Corporate | United States | USD |
| 13 | KRYSTAL BIOTECH INC KRYSTAL BIOTECH INC COM | US5011471027 | 501147102 | 1.957% | $52K | Equity (common) | Corporate | United States | USD |
| 14 | DARLING INGREDIENTS INC DARLING INGREDIENTS INC COM | US2372661015 | 237266101 | 1.936% | $52K | Equity (common) | Corporate | United States | USD |
| 15 | IONIS PHARMACEUTICALS INC IONIS PHARMACEUTICALS INC COM | US4622221004 | 462222100 | 1.857% | $50K | Equity (common) | Corporate | United States | USD |
| 16 | ASTRAZENECA PLC ASTRAZENECA PLC ORD USD0.25 | GB0009895292 | Not reported | 1.827% | $49K | Equity (common) | Corporate | United Kingdom | USD |
| 17 | 10X GENOMICS INC 10X GENOMICS INC CL A COM | US88025U1097 | 88025U109 | 1.810% | $48K | Equity (common) | Corporate | United States | USD |
| 18 | CRISPR THERAPEUTICS AG CRISPR THERAPEUTICS AG NAMEN AKT | CH0334081137 | Not reported | 1.768% | $47K | Equity (common) | Corporate | Switzerland | USD |
| 19 | ROIVANT SCIENCES LTD ROIVANT SCIENCES LTD SHS | BMG762791017 | Not reported | 1.732% | $46K | Equity (common) | Corporate | Bermuda | USD |
| 20 | ABSCI CORP ABSCI CORP COM | US00091E1091 | 00091E109 | 1.705% | $46K | Equity (common) | Corporate | United States | USD |
| 21 | REVOLUTION MEDICINES INC REVOLUTION MEDICINES INC COM | US76155X1000 | 76155X100 | 1.686% | $45K | Equity (common) | Corporate | United States | USD |
| 22 | AGIOS PHARMACEUTICALS INC AGIOS PHARMACEUTICALS INC COM | US00847X1046 | 00847X104 | 1.572% | $42K | Equity (common) | Corporate | United States | USD |
| 23 | AMGEN INC AMGEN INC COM | US0311621009 | 031162100 | 1.542% | $41K | Equity (common) | Corporate | United States | USD |
| 24 | BAYER AG BAYER AG NPV (REGD) | DE000BAY0017 | Not reported | 1.532% | $41K | Equity (common) | Corporate | Germany | EUR |
| 25 | THERMO FISHER SCIENTIFIC INC THERMO FISHER SCIENTIFIC INC COM | US8835561023 | 883556102 | 1.517% | $41K | Equity (common) | Corporate | United States | USD |
| 26 | GILEAD SCIENCES INC GILEAD SCIENCES INC COM | US3755581036 | 375558103 | 1.510% | $40K | Equity (common) | Corporate | United States | USD |
| 27 | BUNGE GLOBAL SA BUNGE GLOBAL SA COM SHS | CH1300646267 | Not reported | 1.507% | $40K | Equity (common) | Corporate | Switzerland | USD |
| 28 | ARROWHEAD PHARMACEUTICALS INC ARROWHEAD PHARMACEUTICALS INC COM | US04280A1007 | 04280A100 | 1.474% | $39K | Equity (common) | Corporate | United States | USD |
| 29 | VERACYTE INC VERACYTE INC COM | US92337F1075 | 92337F107 | 1.461% | $39K | Equity (common) | Corporate | United States | USD |
| 30 | BIOHAVEN LTD BIOHAVEN LTD COM | VGG1110E1079 | Not reported | 1.374% | $37K | Equity (common) | Corporate | British Virgin Islands | USD |
| 31 | NOVONESIS A/S NOVONESIS A/S SER'B'DKK2 | DK0060336014 | Not reported | 1.373% | $37K | Equity (common) | Corporate | Denmark | DKK |
| 32 | PFIZER INC PFIZER INC COM | US7170811035 | 717081103 | 1.344% | $36K | Equity (common) | Corporate | United States | USD |
| 33 | VERTEX PHARMACEUTICALS INC VERTEX PHARMACEUTICALS INC COM | US92532F1003 | 92532F100 | 1.336% | $36K | Equity (common) | Corporate | United States | USD |
| 34 | NOVARTIS AG NOVARTIS AG CHF0.49 (REGD) | CH0012005267 | Not reported | 1.331% | $36K | Equity (common) | Corporate | Switzerland | CHF |
| 35 | UNIQURE NV UNIQURE NV SHS | NL0010696654 | Not reported | 1.227% | $33K | Equity (common) | Corporate | Netherlands | USD |
| 36 | CATALYST PHARMACEUTICALS INC CATALYST PHARMACEUTICALS INC COM | US14888U1016 | 14888U101 | 1.073% | $29K | Equity (common) | Corporate | United States | USD |
| 37 | EXELIXIS INC EXELIXIS INC COM | US30161Q1040 | 30161Q104 | 1.045% | $28K | Equity (common) | Corporate | United States | USD |
| 38 | CULLINAN THERAPEUTICS INC CULLINAN THERAPEUTICS INC COM | US2300311063 | 230031106 | 1.042% | $28K | Equity (common) | Corporate | United States | USD |
| 39 | PROTAGONIST THERAPEUTICS INC PROTAGONIST THERAPEUTICS INC COM | US74366E1029 | 74366E102 | 1.026% | $27K | Equity (common) | Corporate | United States | USD |
| 40 | DYNE THERAPEUTICS INC DYNE THERAPEUTICS INC COM | US26818M1080 | 26818M108 | 1.000% | $27K | Equity (common) | Corporate | United States | USD |
| 41 | CELLDEX THERAPEUTICS INC CELLDEX THERAPEUTICS INC COM NEW | US15117B2025 | 15117B202 | 0.965% | $26K | Equity (common) | Corporate | United States | USD |
| 42 | EDITAS MEDICINE INC EDITAS MEDICINE INC COM | US28106W1036 | 28106W103 | 0.954% | $26K | Equity (common) | Corporate | United States | USD |
| 43 | ARGENX SE ARGENX SE SPONSORED ADR | US04016X1019 | 04016X101 | 0.936% | $25K | Equity (common) | Corporate | Netherlands | USD |
| 44 | VIKING THERAPEUTICS INC VIKING THERAPEUTICS INC COM | US92686J1060 | 92686J106 | 0.931% | $25K | Equity (common) | Corporate | United States | USD |
| 45 | REGENXBIO INC REGENXBIO INC COM | US75901B1070 | 75901B107 | 0.930% | $25K | Equity (common) | Corporate | United States | USD |
| 46 | CG ONCOLOGY INC CG ONCOLOGY INC COM | US1569441009 | 156944100 | 0.902% | $24K | Equity (common) | Corporate | United States | USD |
| 47 | BIONTECH SE BIONTECH SE SPONSORED ADS | US09075V1026 | 09075V102 | 0.876% | $23K | Equity (common) | Corporate | Germany | USD |
| 48 | BIOGEN INC BIOGEN INC COM | US09062X1037 | 09062X103 | 0.823% | $22K | Equity (common) | Corporate | United States | USD |
| 49 | ALLOGENE THERAPEUTICS INC ALLOGENE THERAPEUTICS INC COM | US0197701065 | 019770106 | 0.818% | $22K | Equity (common) | Corporate | United States | USD |
| 50 | IOVANCE BIOTHERAPEUTICS INC IOVANCE BIOTHERAPEUTICS INC COM | US4622601007 | 462260100 | 0.768% | $21K | Equity (common) | Corporate | United States | USD |
| 51 | DANAHER CORP DANAHER CORP COM | US2358511028 | 235851102 | 0.747% | $20K | Equity (common) | Corporate | United States | USD |
| 52 | REPLIGEN CORP REPLIGEN CORP COM | US7599161095 | 759916109 | 0.724% | $19K | Equity (common) | Corporate | United States | USD |
| 53 | MERCK & COMPANY INC MERCK & COMPANY INC COM | US58933Y1055 | 58933Y105 | 0.701% | $19K | Equity (common) | Corporate | United States | USD |
| 54 | SANA BIOTECHNOLOGY INC SANA BIOTECHNOLOGY INC COM | US7995661045 | 799566104 | 0.672% | $18K | Equity (common) | Corporate | United States | USD |
| 55 | VERBIO VEREINIGTE BIOENERGIE SE VERBIO VEREINIGTE BIOENERGIE SE NPV (BR) | DE000A0JL9W6 | Not reported | 0.662% | $18K | Equity (common) | Corporate | Germany | EUR |
| 56 | HALOZYME THERAPEUTICS INC HALOZYME THERAPEUTICS INC COM | US40637H1095 | 40637H109 | 0.649% | $17K | Equity (common) | Corporate | United States | USD |
| 57 | ULTRAGENYX PHARMACEUTICAL INC ULTRAGENYX PHARMACEUTICAL INC COM | US90400D1081 | 90400D108 | 0.597% | $16K | Equity (common) | Corporate | United States | USD |
| 58 | SYENSQO SA/NV SYENSQO SA/NV NPV | BE0974464977 | Not reported | 0.590% | $16K | Equity (common) | Corporate | Belgium | EUR |
| 59 | FMC CORP FMC CORP COM NEW | US3024913036 | 302491303 | 0.583% | $16K | Equity (common) | Corporate | United States | USD |
| 60 | INSMED INC INSMED INC COM PAR $.01 | US4576693075 | 457669307 | 0.581% | $16K | Equity (common) | Corporate | United States | USD |
| 61 | GREEN PLAINS INC GREEN PLAINS INC COM | US3932221043 | 393222104 | 0.580% | $16K | Equity (common) | Corporate | United States | USD |
| 62 | ARCTURUS THERAPEUTICS HOLDINGS INC ARCTURUS THERAPEUTICS HOLDINGS INC COM | US03969T1097 | 03969T109 | 0.548% | $15K | Equity (common) | Corporate | United States | USD |
| 63 | ILLUMINA INC ILLUMINA INC COM | US4523271090 | 452327109 | 0.539% | $14K | Equity (common) | Corporate | United States | USD |
| 64 | REGENERON PHARMACEUTICALS INC REGENERON PHARMACEUTICALS INC COM | US75886F1075 | 75886F107 | 0.536% | $14K | Equity (common) | Corporate | United States | USD |
| 65 | INTELLIA THERAPEUTICS INC INTELLIA THERAPEUTICS INC COM | US45826J1051 | 45826J105 | 0.532% | $14K | Equity (common) | Corporate | United States | USD |
| 66 | NUFARM LTD NUFARM LTD NPV | AU000000NUF3 | Not reported | 0.498% | $13K | Equity (common) | Corporate | Australia | AUD |
| 67 | BIO-TECHNE CORP BIO-TECHNE CORP COM | US09073M1045 | 09073M104 | 0.488% | $13K | Equity (common) | Corporate | United States | USD |
| 68 | BRIDGEBIO PHARMA INC BRIDGEBIO PHARMA INC COM | US10806X1028 | 10806X102 | 0.478% | $13K | Equity (common) | Corporate | United States | USD |
| 69 | BIOMARIN PHARMACEUTICAL INC BIOMARIN PHARMACEUTICAL INC COM | US09061G1013 | 09061G101 | 0.436% | $12K | Equity (common) | Corporate | United States | USD |
| 70 | GENMAB A/S GENMAB A/S SPONSORED ADS | US3723032062 | 372303206 | 0.419% | $11K | Equity (common) | Corporate | Denmark | USD |
| 71 | OXFORD NANOPORE TECHNOLOGIES PLC OXFORD NANOPORE TECHNOLOGIES PLC ORD GBP0.0001 | GB00BP6S8Z30 | Not reported | 0.400% | $11K | Equity (common) | Corporate | United Kingdom | GBP |
| 72 | ZOETIS INC ZOETIS INC CL A | US98978V1035 | 98978V103 | 0.362% | $10K | Equity (common) | Corporate | United States | USD |
| 73 | GENUS PLC GENUS PLC ORD GBP0.10 | GB0002074580 | Not reported | 0.341% | $9K | Equity (common) | Corporate | United Kingdom | GBP |
| 74 | GERON CORP GERON CORP COM | US3741631036 | 374163103 | 0.327% | $9K | Equity (common) | Corporate | United States | USD |
| 75 | TYSON FOODS INC TYSON FOODS INC CL A | US9024941034 | 902494103 | 0.295% | $8K | Equity (common) | Corporate | United States | USD |
| 76 | ROCKET PHARMACEUTICALS INC ROCKET PHARMACEUTICALS INC COM | US77313F1066 | 77313F106 | 0.295% | $8K | Equity (common) | Corporate | United States | USD |
| 77 | ALNYLAM PHARMACEUTICALS INC ALNYLAM PHARMACEUTICALS INC COM | US02043Q1076 | 02043Q107 | 0.292% | $8K | Equity (common) | Corporate | United States | USD |
| 78 | SAREPTA THERAPEUTICS INC SAREPTA THERAPEUTICS INC COM | US8036071004 | 803607100 | 0.281% | $8K | Equity (common) | Corporate | United States | USD |
| 79 | PACIFIC BIOSCIENCES OF CALIFORNIA INC PACIFIC BIOSCIENCES OF CALIFORNIA INC COM | US69404D1081 | 69404D108 | 0.265% | $7K | Equity (common) | Corporate | United States | USD |
| 80 | QIAGEN NV QIAGEN NV ORD SHARES | NL0015002SN0 | Not reported | 0.251% | $7K | Equity (common) | Corporate | Netherlands | USD |
| 81 | DREYFUS TRSY OBLIG CASH M | Not reported | Not reported | 0.107% | $3K | Short-term investment vehicles (cash funds) | Registered fund | United States | USD |